Suppr超能文献

淋巴细胞激活基因3(LAG-3)可调节体内CD4 T细胞被抑制的能力。

Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo.

作者信息

Durham Nicholas M, Nirschl Christopher J, Jackson Christopher M, Elias Jimmy, Kochel Christina M, Anders Robert A, Drake Charles G

机构信息

Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

出版信息

PLoS One. 2014 Nov 5;9(11):e109080. doi: 10.1371/journal.pone.0109080. eCollection 2014.

Abstract

Lymphocyte Activation Gene - 3 (LAG-3) is an immune checkpoint molecule that regulates both T-cell activation and homeostasis. However, the molecular mechanisms underlying LAG-3's function are generally unknown. Using a model in which LAG-3 blockade or absence reliably augmented homeostatic proliferation in vivo, we found that IL-2 and STAT5 are critical for LAG-3 function. Similarly, LAG-3 blockade was ineffective in the absence of regulatory T-cells (Treg), suggesting an important role for LAG-3 in either the responsiveness of conventional T-cells (Tconv) to regulation, or a relative defect in the ability of LAG-3 KO regulatory T-cells (Treg) to suppress the proliferation of Tconv. In this model, LAG-3 KO Treg suppressed proliferation in a manner fairly similar to wild-type (WT) Treg, but LAG-3 KO Tconv were relatively resistant to suppression. Further studies also identified a role for LAG-3 in the induction/expansion of Treg. Finally, we found that LAG-3 blockade (or knockout) led to a relative skewing of naïve CD4 T-cells toward a TH1 phenotype both in vitro and in in vivo. Together, these data suggest that LAG-3 expression on Tconv cells makes them more susceptible to Treg based suppression, and also regulates the development of a TH1 T-cell response.

摘要

淋巴细胞激活基因-3(LAG-3)是一种免疫检查点分子,可调节T细胞的激活和稳态。然而,LAG-3功能的分子机制尚不清楚。利用一种模型,在该模型中LAG-3阻断或缺失可可靠地增强体内稳态增殖,我们发现白细胞介素-2(IL-2)和信号转导子和转录激活子5(STAT5)对LAG-3功能至关重要。同样,在缺乏调节性T细胞(Treg)的情况下,LAG-3阻断无效,这表明LAG-3在传统T细胞(Tconv)对调节的反应性中发挥重要作用,或者在LAG-3基因敲除的调节性T细胞(Treg)抑制Tconv增殖的能力方面存在相对缺陷。在该模型中,LAG-3基因敲除的Treg以与野生型(WT)Treg相当相似的方式抑制增殖,但LAG-3基因敲除的Tconv对抑制相对抵抗。进一步的研究还确定了LAG-3在Treg的诱导/扩增中的作用。最后,我们发现LAG-3阻断(或敲除)在体外和体内均导致幼稚CD4 T细胞相对偏向TH1表型。总之,这些数据表明,Tconv细胞上的LAG-3表达使其更容易受到基于Treg的抑制,并且还调节TH1 T细胞反应的发展。

相似文献

1
Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo.
PLoS One. 2014 Nov 5;9(11):e109080. doi: 10.1371/journal.pone.0109080. eCollection 2014.
4
CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.
Eur J Immunol. 2009 Jun;39(6):1544-51. doi: 10.1002/eji.200838603.
5
Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.
Immunol Cell Biol. 2016 May;94(5):509-19. doi: 10.1038/icb.2016.7. Epub 2016 Jan 14.
6
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation.
PLoS One. 2014 Jan 27;9(1):e86551. doi: 10.1371/journal.pone.0086551. eCollection 2014.
7
Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4 T Cells.
Cell Rep. 2019 Apr 2;27(1):129-141.e4. doi: 10.1016/j.celrep.2019.03.004.
9
Overexpression of Lymphocyte Activation Gene-3 Inhibits Regulatory T Cell Responses in Osteoarthritis.
DNA Cell Biol. 2017 Oct;36(10):862-869. doi: 10.1089/dna.2017.3771. Epub 2017 Aug 11.
10
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
Blood. 2017 Apr 13;129(15):2186-2197. doi: 10.1182/blood-2016-09-741629. Epub 2017 Feb 1.

引用本文的文献

1
Therapeutic potential of targeting LAG-3 in cancer.
J Immunother Cancer. 2025 Jul 8;13(7):e011652. doi: 10.1136/jitc-2025-011652.
2
LAG3 regulates antibody responses in a murine model of kidney transplantation.
J Clin Invest. 2025 May 13;135(13). doi: 10.1172/JCI172988. eCollection 2025 Jul 1.
3
Research hotspots and trends of immunotherapy and melanoma: A bibliometric analysis during 2014-2024.
Hum Vaccin Immunother. 2025 Dec;21(1):2464379. doi: 10.1080/21645515.2025.2464379. Epub 2025 Feb 26.
4
The landscape of plasma proteomic links to human organ imaging.
medRxiv. 2025 Jan 15:2025.01.14.25320532. doi: 10.1101/2025.01.14.25320532.
5
Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials.
Front Immunol. 2024 Nov 26;15:1501613. doi: 10.3389/fimmu.2024.1501613. eCollection 2024.
6
LAG-3-An incompletely understood target in cancer therapy.
FASEB J. 2024 Nov 30;38(22):e70190. doi: 10.1096/fj.202401639R.
8
Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape.
Front Immunol. 2024 Sep 13;15:1424396. doi: 10.3389/fimmu.2024.1424396. eCollection 2024.
9
Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review.
Front Oncol. 2024 Aug 26;14:1402837. doi: 10.3389/fonc.2024.1402837. eCollection 2024.
10
Immune checkpoint inhibitors in infectious disease.
Immunol Rev. 2024 Nov;328(1):350-371. doi: 10.1111/imr.13388. Epub 2024 Sep 9.

本文引用的文献

1
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation.
PLoS One. 2014 Jan 27;9(1):e86551. doi: 10.1371/journal.pone.0086551. eCollection 2014.
2
Peripherally induced tregs - role in immune homeostasis and autoimmunity.
Front Immunol. 2013 Aug 7;4:232. doi: 10.3389/fimmu.2013.00232. eCollection 2013.
3
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.
Nature. 2013 Sep 12;501(7466):252-6. doi: 10.1038/nature12428. Epub 2013 Aug 4.
4
Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy.
Clin Cancer Res. 2013 Sep 15;19(18):4917-24. doi: 10.1158/1078-0432.CCR-12-1972. Epub 2013 Jul 18.
5
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.
6
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.
J Exp Med. 2012 Sep 24;209(10):1713-22, S1-19. doi: 10.1084/jem.20120822. Epub 2012 Sep 10.
7
Phenotypic and functional properties of Helios+ regulatory T cells.
PLoS One. 2012;7(3):e34547. doi: 10.1371/journal.pone.0034547. Epub 2012 Mar 30.
8
Homeostatic maintenance of T cells and natural killer cells.
Cell Mol Life Sci. 2012 May;69(10):1597-608. doi: 10.1007/s00018-012-0968-7. Epub 2012 Mar 30.
9
The role of interleukin-2 during homeostasis and activation of the immune system.
Nat Rev Immunol. 2012 Feb 17;12(3):180-90. doi: 10.1038/nri3156.
10
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Cancer Res. 2012 Feb 15;72(4):917-27. doi: 10.1158/0008-5472.CAN-11-1620. Epub 2011 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验